ArticleACS nanoscience Au2026
Uptake of Nanoparticles as a Model System for Viruses under the Presence of Chloroquine.
Article in ACS nanoscience Au, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the context of fighting SARS-CoV-2 infection, chloroquine and its derivatives have been suggested as treatments. It has been argued that the therapeutic effect is based on the modulation of viral uptake and fate. Similarities to the endocytosis of nanoparticles (NPs) are used here to recapitulate the effect of chloroquine on this process. The possibilities and limits of this approach are discussed. In particular, it is demonstrated that the uptake of NPs can be diminished in the presence of toxic chloroquine concentrations. Chloroquine further reduced acidification of endosomes/lysosomes, which may interfere with the optical readout of fluorescence-labeled NPs. Furthermore, depending on the system used, chloroquine can either increase or decrease transfection upon particle-based DNA delivery.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.